Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: Formulation, optimization, and in vitro characterization

Drug Development and Industrial Pharmacy

Volumn 35, Issue 5, 2009, Pages 583-593

  Mehanna, Mohammed M ^a   Elmaradny, Hoda A ^a   Samaha, Magda W ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Factorial design; Ocular delivery; Optimization; Reverse phase evaporation liposomes; Vesicular system

Indexed keywords

CHOLESTEROL; CIPROFLOXACIN; ANTIINFECTIVE AGENT; DICETYL PHOSPHATE; DRUG CARRIER; EXCIPIENT; EYE DROPS; LIPOSOME; ORGANOPHOSPHATE;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; EVAPORATION; EYE; IN VITRO STUDY; LIPOSOMAL DELIVERY; MEMBRANE VESICLE; PARTICLE SIZE; RESERVOIR; ALGORITHM; ANALYSIS OF VARIANCE; CHEMISTRY; ENDOCYTOSIS; KINETICS; PH; STATISTICAL MODEL;

ALGORITHMS; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CIPROFLOXACIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ENDOCYTOSIS; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; KINETICS; LIPOSOMES; MODELS, STATISTICAL; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; PHOSPHORIC ACID ESTERS;

EID: 67049114625     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802468024     Document Type: Article

References (40)

1. Al-Muhammed, J., Ozer, A. Y., & Hincal, A. A. (1996). In-vivo studies on dexamethasone sodium phosphate liposomes. J. Microencapsul., 13, 293-306 (Pubitemid 126523754)
2. Alonso, M. J. (2004). Nanomedicines for overcoming biological barriers. Biomed. Pharmacother., 58, 168-172
3. Arnardottir, H. B., Sveinsson, S. J., & Kristmundsdottir, T. (1996). The release of clindamycin phosphate from a suspension of different types of liposomes and selected topical dosages forms. Int. J. Pharm., 134, 71-77
4. Baeyens, V., Felt-Baeyens, O., Rougier, S., Pheulpin, S., Boisrame, B., & Gurny, R. (2002). Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infection in dogs. J. Control. Release, 85, 163-168
5. Budai, L., Hajdu, M., Budai, M., Grof, P., Beni, S., Noszal, B., Klebovich, I., & Antal, I. (2007). Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations. Int. J. Pharm., 343, 34-40
6. Burstein, N. L., & Anderson, J. A. (1985). Review: Corneal penetration and ocular availability of drugs. J. Ocul. Pharmacol., 1, 309-326
7. Cortesi, R., Argnani, R., Esposito, E., Dalpiaz, A., Scatturin, A., Bortolotti, F., Lufino, M., Guerrini, R., Cavicchioni, G., Incorvaia, C., Menegatti, E., & Manservigi, R. (2006). Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int. J. Pharm., 317, 90-100
8. Cortesi, R., Romagnoli, R., Menegatti, E., & Esposito, E. (2004). Liposomes containing distamycins: Preparation, characterization and antiproliferation activity. Drug Deliv., 11, 83-88
9. Davies, N. M. (2000). Biopharmaceutical considerations in topical ocular drug delivery. Clin. Exp. Pharmacol. Physiol., 27, 558-562
10. Dillen, K., Vandervoort, J., Mooter, G. V., Verheyden, L., & Ludwig, A. (2004). Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int. J. Pharm., 275, 171-187
11. Ebrahim, S., Peyman, G. A., & Lee, J. P. (2005). Applications of liposomes in ophthamology. Surv. Ophthalmol., 50, 167-182
12. El-Gazayerly, O. N., & Hikal, A. H. (1997). Preparation and evaluation of acetazolamide liposomes as ocular delivery systems. Int. J. Pharm., 158, 121-127
13. Furet, Y. X., Deshusses, J., & Pechere, J. C. (1992). Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolonesusceptible Staphilococcus aureus. Antimicrob. Agents Chemother., 36, 2506-2511
14. Hernandez-Borrell, J., & Montero, M. T. (2003). Does ciprofloxacin interact with neutral bilayers? An aspect related to its antimicrobial activity, Int. J. Pharm., 252, 149-157
15. Jedlovsky, P., & Mezei, M. (2003). Effect of cholesterol on the properties of phospholipid membranes. 1. Structural features. J. Phys. Chem. B, 107, 5311-5321
16. Kaur, I. P., & Kanwar, M. (2002). Ocular preparations: The formulation approach. Drug Dev. Ind. Pharm., 28, 473-493
17. Kaur, I. P., & Smitha, R. (2002). Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm., 28, 353-369
18. Koppcha, M., Lordi, N., & Tojo, K. J. (1991). Evaluation of release from selected thermosoftening vehicles. J. Pharm. Pharmacol., 43, 382-387
19. Law, S. L., & Hung, H. Y. (1998). Properties of acyclovir-containing liposomes for potential ocular delivery. Int. J. Pharm., 161, 253-259
20. Le Bourlais, C. L., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998). Ophthalmic drug delivery systems-recent advances. Prog. Retin. Eye Res., 17, 33-58
21. Lewis, G. A., Mathieu, D., & Phan-Tan-Luu, R. (1999). Pharmaceutical experimental design. New York: Marcel Dekker Inc
22. Liang, W., Levchenko, T. S., & Torchilin, V. P. (2004). Encapsulation of ATP into liposomes by different methods: Optimization of the procedure. J. Microencapsul., 21, 251-261
23. Liu, C., Desai, K. G. H., Tang, X., & Chen, X. (2006). Drug release kinetics of spray-dried chitosan microspheres. Drying Tech., 24, 769-776
24. Maffei, P., Lombardi Borgia, S., Sforzini, A., Bergamante, V., & Ceschel, G. C. (2004). Mucoadhesive tablets for buccal administration containing sodium nimesulide. Drug Deliv., 11, 225-230
25. Mainardes, R. M., Urban, M. C., Cinto, P. O., Khalil, N. M., Chaud, M. V., Evangelista, R. C., & Gremiao, M. P. (2005). Colloidal carriers for ophthalmic drug delivery. Curr. Drug Targets, 6, 363-371
26. Nagarsenker, M. S., Londhe, V. Y., & Nadkarni, G. D. (1999). Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int. J. Pharm., 190, 63-71
27. Perugini, P., Genta, I., Pavanetto, F., Conti, B., Scalia, S., & Baruffini, A. (2000). Study on glycolic acid delivery by liposomes and microspheres. Int. J. Pharm., 196, 51-61
28. Peschka-Suss, R., Dennehy, C., & Szoka, F. (1998). A simple in vitro model to study the release kinetics of liposome encapsulated material. J. Control. Release, 56, 41-51
29. Puglisi, G., Fresta, M., Mazzone, G., Furneri, P. M., & Tempera, G. (1995). Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity. Int. J. Pharm., 118, 65-76
30. Santo, P., Bufali, S., Pisano, C., Bucci, F., Barbarino, M., Santaniello, M., Carminati, P., & Luisi, P. L. (2004). Novel camptothecin analogue (gimatecan)- containing liposomes prepared by the ethanol injection method. J. Liposome Res., 14, 87-109
31. Sasaki, H., Nagono, T., Sakanaka, K., Kawakami, S., Nishida, K., Nakamura, J., Khikawa, N., Iwashita, J., Nakamura, T., & Nakashima, M. (2003). Oneside coated insert as unique ophthalmic drug delivery system. J. Control. Release, 92, 241-247
32. Seham, A. E., Sabry, S. B., & Alia, A. B. (1996). Optimization of a reconstitutable suspension of rifampicin using 24 factorial design. Drug Dev. Ind. Pharm., 22, 623-630
33. Seth, A. K., & Misra, A. (2002). Mathematical modelling of preparation of acyclovir liposomes: Reverse phase evaporation method. J. Pharm. Pharm. Sci., 5, 285-291
34. Shell, J. W. (1984). Ophthalmic drug delivery systems. Surv. Ophthalmol., 29, 117-128
35. Shell, J. W., & Baker, R. (1974). Diffusional systems for controlled release of drugs to the eye. Ann. Ophthalmol., 6, 1037-1043
36. Sun, K. X., Wang, A. P., Huang, L. J., Liang, R. C., & Liu, K. (2006). Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics. Acta Pharmacol. Sin., 41, 1094-1098
37. Szoka, F., & Papahadjopoulos, D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc. Natl. Acad. Sci. USA, 75, 4194-4198
38. Verly, R. M., Rodrigues, M. A., Daghastanli, K. R. P., Denadai, A. M. L., Cuccovia, I. M., Bloch, C.Jr, Frézard, F., Santoro, M. M., Piló-Veloso, D., & Bemquerer, M. P. (2008). Effect of cholesterol on the interaction of the amphibian antimicrobial peptide DD K with liposomes. Peptides, 29, 15-24
39. Wen, A. H., Choi, M. K., (2006). Formulation of liposome for topical delivery of arbutin. Arch. Pharm. Res., 29, 1187-1192
40. Zimmer, A., & Kreuter, J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv. Drug Deliv. Rev., 16, 61-73